Smart Medical Implant System with AI-Driven Personalized Treatment

Publication ID: 24-11857671_0008_PTD
Published: October 28, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Smart Medical Implant System with AI-Driven Personalized Treatment,” Published Technical Disclosure No. 24-11857671_0008_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857671_0008_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,671.

Summary of the Inventive Concept

A novel medical implant system that integrates an implantable medical drug delivery device with AI, IoT, blockchain, and nanomaterial technologies to provide personalized treatment, real-time monitoring, and optimized drug delivery rates.

Background and Problem Solved

The original patent addressed the limitation of initial drug 'burst' in existing drug implants. However, the new inventive concept takes a significant leap forward by synergistically combining the patented implantable medical drug delivery device with distinct technologies to create a more powerful system that provides personalized medical treatment, real-time monitoring, and optimized drug delivery rates.

Detailed Description of the Inventive Concept

The smart medical implant system consists of the implantable medical drug delivery device with a non-homogenous mixture of at least two different types of drug materials. This device is integrated with an AI-powered diagnostic module that analyzes patient data to optimize drug delivery rates. Additionally, the system incorporates an IoT-enabled sensor network to enable real-time monitoring of medical implant performance, and utilizes blockchain technology to securely store and analyze patient data. Furthermore, the system can include a nanomaterial-based coating for targeted drug release and a machine learning algorithm that predicts optimal drug delivery schedules. The AI-driven analytics module provides real-time feedback on drug delivery rates and patient response, enabling personalized treatment planning.

Novelty and Inventive Step

The new claims introduce a novel combination of the patented implantable medical drug delivery device with AI, IoT, blockchain, and nanomaterial technologies, providing a synergistic system that is more powerful and effective than the original patent. The inventive step lies in the integration of these distinct technologies to create a smart medical implant system that provides personalized treatment, real-time monitoring, and optimized drug delivery rates.

Alternative Embodiments and Variations

Alternative embodiments of the smart medical implant system could include variations in the AI-powered diagnostic module, such as using different machine learning algorithms or integrating with other diagnostic tools. The IoT-enabled sensor network could be replaced with other types of sensor technologies, and the blockchain technology could be substituted with other secure data storage solutions. The nanomaterial-based coating could be modified to target specific drug release profiles, and the machine learning algorithm could be adapted to predict optimal drug delivery schedules based on different patient data.

Potential Commercial Applications and Market

The smart medical implant system has significant commercial potential in the healthcare industry, particularly in the areas of personalized medicine, remote patient monitoring, and optimized drug delivery. The system could be marketed to hospitals, clinics, and pharmaceutical companies, and could potentially disrupt the existing medical implant market by providing a more effective and efficient solution for patients.

CPC Classifications

SectionClassGroup
A A61 A61K9/0024
A A61 A61K31/4468
A A61 A61K31/485
A A61 A61K45/06

Original Patent Information

Patent NumberUS 11,857,671
TitleMedical implant